The Food and Drug Administration is suing one company for allegedly failing to properly test its ingredients.
Related Articles Read More >
Navigating the new regulatory terrain pharma companies face with IRA and 340B
FDA warns against compounded oral ketamine for psychiatric disorders
FDA resolves drug shortage for Novartis’ prostate cancer drug Pluvicto
